Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation

by Michael C. Repka, Nima Aghdam, Shaan K. Kataria, Lloyd Campbell, Simeng Suy, Sean P. Collins, Eric Anderson, Jonathan W. Lischalk, Brian T. Collins
Published 2017-10-01

Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non‐small cell lung cancer

by Nima Aghdam, Mary McGunigal, Haijun Wang, Michael C. Repka, Mihriye Mete, Stephen Fernandez, Chiranjeev Dash, Waddah B. Al‐Refaie, Keith R. Unger
Published 2020-08-01

Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk

by Michael C. Repka, Siyuan Lei, Lloyd Campbell, Simeng Suy, Jean-Marc Voyadzis, Christopher Kalhorn, Kevin McGrail, Walter Jean, Deepa S. Subramaniam, Jonathan W. Lischalk, Sean P. Collins, Brian T. Collins
Published 2018-09-01

Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer

by Nima Aghdam, Nima Aghdam, Michael C. Repka, Mary McGunigal, Abby Pepin, Ima Paydar, Sonali Rudra, Nitika Paudel, Monica Pernia Marin, Simeng Suy, Sean P. Collins, Willard Barnes, Brian T. Collins
Published 2020-12-01

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast...

by Jonathan W. Lischalk, MD, Hao Chen, PhD, Michael C. Repka, MD, Lloyd D. Campbell, CMD, Olusola Obayomi-Davies, MD, Shaan Kataria, MD, Thomas P. Kole, MD, PhD, Sonali Rudra, MD, Brian T. Collins, MD
Published 2018-07-01